Skip to main content

Table 2 FDG and RGD uptake in Hodgkin and non-Hodgkin patients before (C0) and after (C2) chemotherapy

From: Angiogenesis imaging study using interim [18F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence

FDG

C0

C2

Hodgkin

Non-Hodgkin

p-value

Hodgkin

Non-Hodgkin

p-value

n = 6

n = 13

n = 6

n = 10

SUVmax ± SD

14.8 ± 4.7

17.0 ± 8.6

0.56

2.6 ± 1.3

5.1 ± 2.0

0.02

MTV ± SD

91.8 ± 60

254 ± 306

0.22

33 ± 65

27.6 ± 40.6

0.4

RGD

n = 6

n = 13

 

n = 5

n = 7

 

SUVmax ± SD

3.9 ± 1.4

1.9 ± 1.1

0.002

3.1 ± 1.1

3.6 ± 1.8

0.6

ATV ± SD

145 ± 125

3.2 ± 9

 < 0.001

46 ± 45

45 ± 99

0.9